Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Value · Guggenheim

S&P 500 Pure Value Fund Class C (RYVVX)

Ticker RYVVX · · Holdings as of Jun 30, 2026

Expense ratio
2.29%$229/yr per $10k
5-yr return
+11.3%annualized
1-yr return
+14.7%as of Dec 2025
Net assets
$63.2Mall share classes
Holdings
122

Bottom line

Is RYVVX a good fund? The bottom line

RYVVX is the Class C share class of S&P 500 Pure Value Fund, a managed large value mutual fund from Guggenheim.

Annual fees run 2.29% — about $229 a year on every $10,000 invested, more expensive than 100% of large value funds we track.

It returned +14.7% over one year, +11.3% a year over five years, +7.9% a year over ten (as of Dec 31, 2025, per its prospectus).

With $63.2 million in net assets and 122 holdings, its largest position is Centene Corp (2.7%) and the top 10 make up 20.6% of the portfolio.

The closest lower-cost alternative we found is RPV (0.35%, 78% top-holdings overlap).

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (2.29%)
  • 12b-1 marketing fee of 1% a year
  • High turnover (2,128% a year) can mean more taxable distributions

Updated Nov 19, 2026

What RYVVX invests in

The S&P 500 Pure Value Fund (the Fund) seeks to provide investment results that match, before fees and expenses, the performance of a benchmark for large-cap value securities on a daily basis. The Funds current benchmark is the S&P 500 Pure Value Index (the underlying index).

The Fund employs as its investment strategy a program of investing in the common stock of companies that are generally within the capitalization range of the underlying index and derivative instruments, which primarily consist of equity index swaps, futures contracts, and options on securities, futures contracts, and stock indices. While the Fund may write (sell) and purchase swaps, it expects primarily to purchase swaps. Equity index swaps and futures and options contracts enable the Fund to pursue its investment objective without investing directly in the securities included in the underlying index or in the same proportion that those securities are represented in the underlying index. Certain of the Funds derivatives investments may be traded in the over-the-counter (OTC) market. Under normal circumstances, the Fund will invest at least 80% of its net assets, plus any borrowings for…

From the fund's prospectus (filed Jul 29, 2026).

RYVVX performance

Fund calendar-year total returns, 2016–2025 2016: +16.5%; 2017: +15.1%; 2018: −14.0%; 2019: +22.3%; 2020: −11.0%; 2021: +31.1%; 2022: −3.3%; 2023: +5.7%; 2024: +9.9%; 2025: +15.7% +17% 2016 +15% 2017 −14% 2018 +22% 2019 −11% 2020 +31% 2021 −3% 2022 +6% 2023 +10% 2024 +16% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
RYVVX+14.7%+11.3%+7.9%
Large Value median+13.6%+11.3%+10.2%

Source: Fund prospectus, as of Dec 31, 2025

Full RYVVX performance history →

What RYVVX costs

On a $10,000 investment, RYVVX's 2.29% expense ratio costs about $229 a year. The prospectus estimates $2,672 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.

See the full RYVVX fee table →

RYVVX top 10 holdings

#Holding% of fund
1Centene Corp CNC2.73%
2Humana Inc HUM2.47%
3Archer Daniels Midland Company ADM2.21%
4Bunge Global Sa BG2.20%
5Cvs Health Corp CVS2.14%
6Ford Motor Co F2.00%
7Dow Inc DOW1.78%
8General Motors Company GM1.71%
9Target Corp TGT1.66%
10Cigna Group (the) CI1.66%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 20.6% of the fund. See all top 25 holdings and asset mix →

Alternatives to RYVVX

Closest equivalent at other fund companies
FamilyFundExpense ratioOverlap
InvescoRPV Invesco S&P 500 Pure Value ETF0.35%78% Compare

More funds like RYVVX →

RYVVX FAQ

What is the expense ratio of RYVVX?
RYVVX's expense ratio is 2.29%, which works out to about $229 a year for every $10,000 invested. The prospectus estimates total costs of $2,672 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is RYVVX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (2.29%); 12b-1 marketing fee of 1% a year; high turnover (2,128% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does RYVVX hold?
RYVVX's largest holdings are Centene Corp (2.7%), Humana Inc (2.5%), Archer Daniels Midland Company (2.2%), Bunge Global Sa (2.2%), Cvs Health Corp (2.1%). It holds 122 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is RYVVX's 5-year return?
RYVVX returned +11.3% a year over the five years ending Dec 31, 2025, and +7.9% a year over ten years. Past performance does not guarantee future results.
Does RYVVX have a sales load?
No. RYVVX has no front-end sales charge. It may charge a deferred sales charge of up to 1% if sold early.
What is a cheaper alternative to RYVVX?
RPV (Invesco S&P 500 Pure Value ETF) overlaps about 78% with RYVVX and charges 0.35%.
Who manages RYVVX?
RYVVX is offered by Guggenheim through Rydex Series Funds.